approved

Приложение 4 на ПЛС от 02.05.2020 г.

Unique identificator:  04340aba-ab53-457c-b451-dc4cd6180c12

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-05-04 15:57:54
  • Created by: georgi_sivchev
  • Updated at: 2020-05-04 15:57:54
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Beclometasone № 6763/26.01.2010 Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o. Chech Republic 21.1 4.22 25.32 6% 1.27 22.37 4.47 26.84 18% 3.8 26.17 5.23 31.4 НСР-1804/25.11.2013 11.12.2013 11.12.2013 Неактивен 3123
Beclometasone № 6763/26.01.2010 Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o. Chech Republic 21.67 4.33 26 6% 1.3 22.97 4.59 27.56 18% 3.9 26.87 5.37 32.24 КЦ-2303/10.06.2011 промяна на обстоятелства КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 3123
Beclometasone 20030347 Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o. Chech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland), Waterford, Ирландия 29.32 5.86 35.18 6% 1.76 31.08 6.22 37.3 18% 5.28 36.36 7.27 43.63 промяна в обстоятелства НСР-5346/18.12.2014; промяна в обстоятелства НСР-5711/18.02.2015; Цената е заличена с решение НСР-7130/24.09.2015 ( в сила от 16.10.2015 ) НСР-5072/21.11.2014 08.12.2014 08.12.2014 Заличен 3354
Beclometasone № 6764/26.01.2010 Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o. Chech Republic 29.75 5.95 35.7 6% 1.79 31.54 6.31 37.85 18% 5.36 36.9 7.38 44.28 КЦ-2303/10.06.2011 промяна на обстоятелства КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 3354
Salbutamol 20010556 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 5.07 1.01 6.08 7% 0.35 5.42 1.08 6.5 20% 1.01 6.43 1.29 7.72 Протокол 191/29.09.2016 НСР-5962/01.04.2015.; НСР-12237/03.04.2017 16.04.2015 02.05.2017 Заличен 3785
Salbutamol 20010556 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 5.07 1.01 6.08 7% 0.35 5.42 1.08 6.5 20% 1.01 6.43 1.29 7.72 Протокол 191/29.09.2016 НСР-5962/01.04.2015. 16.04.2015 02.11.2016 Неактивен 3785
Salbutamol 20010556 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Czech Republiс; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 5.07 1.01 6.08 7% 0.35 5.42 1.08 6.5 20% 1.01 6.43 1.29 7.72 НСР-5962/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3785
Salbutamol 20010556 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 5.1 1.02 6.12 7% 0.36 5.46 1.09 6.55 20% 1.02 6.48 1.3 7.78 НСР-2631/03.02.2014 20.02.2014 20.02.2014 Неактивен 3785
Salbutamol № 121/ 09.12.2010; КЦРР-1199/13.08.2012 г. Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 5.42 1.08 6.5 7% 0.38 5.8 1.16 6.96 20% 1.08 6.88 1.38 8.26 НСР-70/07.06.2013 26.06.2013 26.06.2013 Неактивен 3785
Salbutamol 6618/11.01.2010 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 6.83 1.37 8.2 7% 0.48 7.31 1.46 8.77 20% 1.37 8.68 1.74 10.42 КЦРР-1199/13.08.2012 28.08.2012 28.08.2012 Неактивен 3785
Salbutamol 6618/11.01.2010 Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 11.58 2.32 13.9 8% 0.93 12.51 2.5 15.01 20% 2.32 14.83 2.97 17.8 КЦ-1660/25.06.2010 промяна на обстоятелства КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 3785
Salbutamol 20010555 Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva B.V., Нидерландия Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 4.6 0.92 5.52 7% 0.32 4.92 0.98 5.9 20% 0.92 5.84 1.17 7.01 КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г.; НСР-17173/09.11.2018 КЦ-700/09.03.2009 24.03.2009 02.12.2018 Активен 663
Salbutamol 20010555 Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 4.6 0.92 5.52 7% 0.32 4.92 0.98 5.9 20% 0.92 5.84 1.17 7.01 КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г. КЦ-700/09.03.2009 24.03.2009 02.06.2017 Неактивен 663
Salbutamol 20010555 Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 Teva Czech Industries s.r.o., Чешка република Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland 4.6 0.92 5.52 7% 0.32 4.92 0.98 5.9 20% 0.92 5.84 1.17 7.01 КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015 КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 663
Gliclazide 20120076 Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 Екофарм Груп АД, България Екофарм ЕООД 5.8 1.16 6.96 7% 0.41 6.21 1.24 7.45 20% 1.16 7.37 1.47 8.84 промяна на обстоятелства решение КЦPP-1699/27.11.2012 КЦРР-1295/21.08.2012; НСР-17061/26.10.2018 10.11.2018 02.12.2018 Активен 1355
Gliclazide 20120076 Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 Екофарм Груп АД, България Екофарм ЕООД 5.67 1.13 6.8 7% 0.4 6.07 1.21 7.28 20% 1.13 7.2 1.44 8.64 промяна на обстоятелства решение КЦPP-1699/27.11.2012 КЦРР-1295/21.08.2012 11.09.2012 11.09.2012 Неактивен 1355
Gliclazide 20120076 Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 Екофарм Груп АД, България Екофарм ЕООД 5.67 1.13 6.8 7% 0.4 6.07 1.21 7.28 20% 1.13 7.2 1.44 8.64 промяна на обстоятелства решение КЦPP-1699/27.11.2012 КЦРР-1295/21.08.2012 11.09.2012 11.09.2012 Неактивен 1355
Vancomycin ІІ-14746/08.11.2006 г. Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 19.11 3.82 22.93 6% 1.15 20.26 4.05 24.31 18% 3.44 23.7 4.74 28.44 НСР-1944/06.12.2013; НСР-10087/18.08.2016 24.12.2013 02.10.2016 Заличен 2342
Vancomycin ІІ-14746/08.11.2006 г. Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 19.11 3.82 22.93 6% 1.15 20.26 4.05 24.31 18% 3.44 23.7 4.74 28.44 НСР-1944/06.12.2013 24.12.2013 24.12.2013 Неактивен 2342
Vancomycin ІІ-14746/08.11.2006 г. Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 22.86 4.57 27.43 6% 1.37 24.23 4.85 29.08 18% 4.11 28.34 5.67 34.01 КЦ-527/13.02.2009 02.03.2009 02.03.2009 Неактивен 2342
Reboxetine 990065 Edronax, Tablet, 4, mg, Pack: 60 Pfizer Europe MA EEIG, Белгия Pfizer Italia S.r.l., Италия 31.33 6.27 37.6 4% 1.25 32.58 6.52 39.1 16% 5.01 37.59 7.52 45.11 Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 КЦ-707/09.03.2009; НСР-20812/13.02.2020 28.02.2020 02.03.2020 Активен 658
Reboxetine 990065/22.06.2006 г. Edronax, Tablet, 4, mg, Pack: 60 Pfizer Europe MA EEIG, Белгия Pfizer Italia S.r.l., Italy 19.85 3.97 23.82 6% 1.19 21.04 4.21 25.25 18% 3.57 24.61 4.92 29.53 Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 КЦ-707/09.03.2009 25.03.2009 02.01.2019 Неактивен 658
Reboxetine 990065/22.06.2006 г. Edronax, Tablet, 4, mg, Pack: 60 Pfizer Europe MA EEIG, Обединено Кралство Pfizer Italia S.r.l., Italy 19.85 3.97 23.82 6% 1.19 21.04 4.21 25.25 18% 3.57 24.61 4.92 29.53 Протокол 140/22.10.2015 КЦ-707/09.03.2009 25.03.2009 25.03.2009 Неактивен 658
Reboxetine 0066/22.06.2007 г. Edronax, Tablet, 4, mg, Pack: 20 Pfizer Europe MA EEIG, Обединено Кралство Pfizer Italia S.r.l., Italy 13.12 2.62 15.74 6% 0.79 13.91 2.78 16.69 18% 2.36 16.27 3.25 19.52 Цената се заличава с решение НСР-2231/20.12.2013 КЦРР-1071/26.07.2012 12.09.2012 12.09.2012 Заличен 1357
Reboxetine 0066/22.06.2007 г. Edronax, Tablet, 4, mg, Pack: 20 Pfizer Europe MA EEIG, Обединено Кралство Pfizer Italia S.r.l., Italy 14.08 2.82 16.9 6% 0.84 14.92 2.98 17.9 18% 2.53 17.45 3.49 20.94 КЦ-707/09.03.2009 25.03.2009 25.03.2009 Неактивен 1357
Showing 4401 to 4426 of 17361 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте